Medical Device Coatings
The global medical device coating market reached about $6.1 billion in 2013. This market is expected to grow to $6.3 billion in 2014 and $9 billion in 2019, with a compound annual growth rate (CAGR) of 7.3% from 2014 to 2019.
- An overview of the global markets for medical device coatings and related technologies.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- Information on the specific drivers, trends, and challenges for different segments of the market.
- Valuable insight into future trends, details on products, and information on coating manufacturers who supply the materials, the medical device companies which use it and the members of the healthcare that influence purchases.
- Details pertaining to technologies including alloy, ceramic, combination, energy-absorbing, energy-emitting, micro and nano, protective polymer, and surface treatment.
- Comprehensive profiles of major players in the industry.
SCOPE AND FORMAT
This study looks at medical device coatings and surface treatments from the perspective of both the supply and demand side of the equation that is from coating manufacturers that supply the materials, the medical device companies that use it and the members of the healthcare community who influence purchases.
Consistent with the scope of the study, the format of this report is arranged to present its five-year forecasts as a series of tables. Each of those tables presents U.S. current dollar demand values for coatings and surface processes for 2012 and 2013, and the five-year period from 2014 through 2019. Separate sets of forecasts are presented for the:
- Eight types of coatings and surface treatment technologies.
- Nineteen healthcare areas that correspond to FDA medical device review panels.
- United States, European Union, other developed nations and the rest of the world.
In addition to forecast tables, the report includes informational tables. These summarize FDA Freedom of Information act data about generic types of devices, their use within each healthcare area, and the regulatory pathway and burdens imposed upon them. Supplier detail includes the global distribution of production facilities, location and coating-related proprietary names. An appendix contains the abstract of major coating-related patents, including their initial assignees.
James Wilson is a technology analyst, who has previously served as editor of the Princeton Business Journal and as senior science and technology editor for Hearst Magazines. He is a past member of the National Association of Science Writers and the American Medical Writers Association. Wilson served on the adjunct faculty of Temple University and on the staffs of Drexel University and the Academy of Natural Sciences.
The global medical device coating market reached $4.8 billion in 2010 and $5.4 billion in 2011. The market is expected to grow from $5.7 billion in 2012 to nearly $8 billion in 2017, a five-year compound annual growth rate (CAGR) of 6.7%.
- The global medical device coatings market will increase from an estimated $4.2 billion in 2008 to $4.7 billion in 2009. It should reach $7.5 billion in 2014, a compound annual growth rate (CAGR) of 9.9%.
- The NAFTA region has the largest share of the market with an estimated $2.1 billion in sales in 2008. This is expected to increase to $2.4 billion in 2009 and $3.9 billion in 2014, for a CAGR of 10.2%.
- The European Union has the second largest share of the market and is expected to generate $1.1 billion in 2008. This should increase slightly in 2009 and reach $2.0 billion in 2014, for a CAGR of 10.6%.
- The value of worldwide sales for all categories of coatings and surface treatment processes used in manufacturing medical devices reached $2.96 billion in 2005.
- Fueled by an explosive growth in high-value combination products, such as arterial stents and antimicrobial-coated catheters, the global medical device coatings business will experience an average annual growth rate (AAGR) of 12.4%, reaching worldwide sales of $5.31 billion by 2010.
- The swift acceptance of drug-eluting stents as a "gold standard" treatment by surgeons around the globe suggests that the demand for other coated versions of existing medical devices will be equally swift. Our analysis further suggests that there will be a correspondingly swift acceptance of new coated devices as they are introduced.